Semax – 25mg | Research Compound

Semax – 25mg | Research Compound

Semax is a synthetic heptapeptide derived from the ACTH(4-10) amino acid sequence. It is studied in laboratory settings for its molecular characteristics and interactions with neurotrophin-related, gene-expression, and cellular signaling pathways.

Key Research Areas:

• BDNF-Related Signaling — Laboratory investigation of Semax in relation to brain-derived neurotrophic factor (BDNF) and associated molecular signaling pathways.
• Gene-Expression Research — Investigation of Semax-associated changes in gene-expression patterns and related molecular processes.
• Receptor & Cellular Signaling — Laboratory characterization of Semax interactions with receptor systems and downstream cellular signaling.
• Neurotrophin Pathway Research — Investigation of molecular pathways associated with neurotrophin-related signaling.
• Peptide Interaction Research — Laboratory examination of Semax and its interactions with endogenous peptide and enzyme systems.

Product Specifications:

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Synthetic heptapeptide derived from ACTH(4-10)
• Molecular Formula: C₃₇H₅₁N₉O₁₀S
• Molecular Weight: ~813.0 g/mol
• 25mg lyophilized research compound per vial
• ≥99% purity via HPLC and mass spectrometry
• Third-party COA available
• Store under appropriate controlled laboratory conditions and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved.